NIH-funded research R01 grant

Investigating genetic factors and drug discovery to improve brain function in Down syndrome

Official title: Large-scale Genetic Investigation and Drug Discovery to Counteract Down Syndrome Neural Deficits

Funded at Univ of Massachusetts Med Sch Worcester · NIH-11103227 · Data updated 2026-11-12

This study is exploring how certain genes linked to Down syndrome affect brain development and behavior, using zebrafish to find new treatments that might help improve brain function for people with this condition.

More Down Syndrome research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester
NIH-funded
Lab location1 site (Worcester, United States)
Project startJune 5, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$837,498
NIH project number5R01HD115159-02
Project IDNIH-11103227 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Down syndrome, particularly those experiencing intellectual disabilities.

Less likely to help

Patients without Down syndrome or those whose intellectual disabilities are not related to genetic factors on chromosome 21 may not benefit from this research.

What this research studies

This research focuses on understanding the genetic influences of Down syndrome, which is the most common genetic cause of intellectual disability. By using zebrafish as a model organism, researchers will manipulate genes from chromosome 21 to observe their effects on brain development and behavior. The study aims to identify small molecules that could potentially prevent or reverse brain abnormalities associated with Down syndrome. This innovative approach combines genetic manipulation with high-throughput drug screening to find new therapeutic options.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve cognitive function and quality of life for individuals with Down syndrome.

How similar studies have gone: Previous research using zebrafish models has shown promise in identifying compounds that enter clinical trials, indicating potential success for this novel approach.

Where this research is happening

  • Univ of Massachusetts Med Sch Worcester
    Worcester, United States
    Active

Researchers

  • Principal investigator: Thyme, Summer B — Univ of Massachusetts Med Sch Worcester
  • Study coordinator: Thyme, Summer B

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.